GlassScriptPhysician profile
Scott C Mcferren
NPI 1396108098
$8,193.76
in general payments reported to CMS, 2019-2025
46 companies · $1,820 in 2025
The $1,820 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.09 · 2021: $256 · 2022: $3,090 · 2023: $1,010 · 2024: $1,957 · 2025: $1,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,673 · Education: $99.99 · Entertainment: $14.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,673.17 |
| Education | $99.99 |
| Entertainment | $14.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,487.70 | 2019-2024 | Lithovue, Rezum Generator |
| Janssen Biotech, INC. | $826.67 | 2021-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $690.28 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $431.43 | 2021-2025 | Provenge |
| Merck Sharp & Dohme LLC | $386.33 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Procept Biorobotics Corporation | $367.71 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Ferring Pharmaceuticals INC. | $313.55 | 2024-2025 | Adstiladrin |
| Astellas Pharma US INC | $298.67 | 2021-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $261.12 | 2022-2025 | |
| Abbvie INC. | $179.94 | 2022-2025 | |
| Olympus America INC. | $168.42 | 2021-2024 | Itind System |
| Axonics, INC. | $130.93 | 2022-2023 | Bulkamid, Axonics |
| Myovant Sciences INC. | $119.21 | 2021-2022 | |
| Coloplast Corp | $115.46 | 2022-2025 | Titan |
| Verity Pharmaceuticals INC. | $103.55 | 2023-2024 | Trelstar |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mcferren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.